Agents inhibit antineoplastic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Tumor Cells, Cultured Cell Line, Tumor HL-60 Cells Cell Line Cells, Cultured HT29 Cells

Organisms5

Narcissus Mice, Nude Aster Plant Olacaceae Mice, Inbred BALB C

Diseases15

Leukemia P388 Neoplasms Sarcoma 180 Leukemia L1210 Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Leukemia Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms Phlebitis Carcinoma, Ehrlich Tumor Lymphoma Mammary Neoplasms, Experimental

Chemicals and Drugs80

Antineoplastic Agents Antineoplastic Agents, Phytogenic Amaryllidaceae Alkaloids Ellipticines Bibenzyls Doxorubicin Antibiotics, Antineoplastic Thiadiazines Bryostatins Antineoplastic Agents, Alkylating Ancitabine Gallium Depsipeptides Cisplatin Paclitaxel 6-Mercaptopurine Aminoacridines Epothilones Lactones Antimetabolites, Antineoplastic Daunorubicin Fluorouracil Bleomycin Etoposide Prodrugs Macrolides Methotrexate Camptothecin Stilbenes Enzyme Inhibitors Vincristine Isoquinolines Cyclophosphamide Caspases Taxoids DNA Phospholipid Ethers RNA, Messenger Reactive Oxygen Species Sulindac Amsacrine Vanadium Compounds Hazardous Substances Thiosemicarbazones Floxuridine 2-Propanol Carmustine Cytarabine Topoisomerase II Inhibitors Farnesyltranstransferase Drugs, Investigational Isocoumarins Nitrogen Mustard Compounds Dioxoles Suramin Alkaloids Plant Extracts Mitomycin Topoisomerase I Inhibitors Azacitidine DNA Adducts DNA Topoisomerases, Type II Anti-Inflammatory Agents, Non-Steroidal Nitrosourea Compounds Pyrones Pyrazines Hydrazones Sulfonamides DNA, Neoplasm Alkylating Agents Razoxane Phosphorylcholine Organoplatinum Compounds Octreotide Glutathione Transferase Lomustine Piperazines Mitomycins Dehydroascorbic Acid Anthracyclines

Analytical, Diagnostic and Therapeutic Techniques and Equipment23

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Drug Evaluation Xenograft Model Antitumor Assays Neoplasms, Experimental Drug Administration Schedule Neoplasm Transplantation Clinical Trials as Topic Gloves, Protective Treatment Outcome Protective Devices Equipment and Supplies, Hospital Protective Clothing Inhibitory Concentration 50 Drug Compounding Antineoplastic Protocols Tumor Stem Cell Assay Comet Assay Lethal Dose 50 Mutagenicity Tests Blotting, Western Mammary Neoplasms, Experimental

Phenomena and Processes24

Drug Synergism Apoptosis Cell Survival Molecular Structure Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cell Division Drug Resistance Cell Cycle Cell Proliferation Biotransformation Drug Interactions DNA Damage Stereoisomerism Time Factors Kinetics Structure-Activity Relationship Dental Physiological Processes Inhibitory Concentration 50 Drug Resistance, Multiple DNA Adducts Lethal Dose 50 Gene Expression Regulation, Neoplastic Metabolic Detoxication, Drug

Disciplines and Occupations1

Oncology Nursing

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care17

Clinical Trials as Topic Occupational Exposure Treatment Outcome Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Antineoplastic Protocols Pharmacies Oncology Service, Hospital Nurses Hospitals Pharmacists Cancer Care Facilities

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Named Groups Health Care

Antineoplastic Agents Antineoplastic Agents, Phytogenic Leukemia P388 Amaryllidaceae Alkaloids Narcissus Ellipticines Bibenzyls Doxorubicin Drug Screening Assays, Antitumor Antibiotics, Antineoplastic Thiadiazines Bryostatins Antineoplastic Agents, Alkylating Ancitabine Neoplasms Gallium Depsipeptides Tumor Cells, Cultured Cisplatin Paclitaxel 6-Mercaptopurine Drug Synergism Apoptosis Aminoacridines Epothilones Cell Line, Tumor Cell Survival Sarcoma 180 Molecular Structure Lactones Leukemia L1210 Antimetabolites, Antineoplastic Daunorubicin Fluorouracil Bleomycin Dose-Response Relationship, Drug Etoposide Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Prodrugs Drug Evaluation, Preclinical Drug Evaluation Cell Division Xenograft Model Antitumor Assays Drug Resistance Macrolides Neoplasms, Experimental Methotrexate Camptothecin Stilbenes Cell Cycle Mice, Nude HL-60 Cells Enzyme Inhibitors Cell Proliferation Lung Neoplasms Drug Administration Schedule Vincristine Isoquinolines Neoplasm Transplantation Biotransformation Drug Interactions Breast Neoplasms DNA Damage Cyclophosphamide Stereoisomerism Time Factors Clinical Trials as Topic Leukemia Cell Line Kinetics Ovarian Neoplasms Colonic Neoplasms Caspases Taxoids Prostatic Neoplasms Structure-Activity Relationship DNA Phospholipid Ethers RNA, Messenger Reactive Oxygen Species Cells, Cultured Gloves, Protective Aster Plant Occupational Exposure Olacaceae Treatment Outcome Medical Secretaries Oncology Nursing Laundering Sulindac Protective Devices Dental Physiological Processes Equipment and Supplies, Hospital Protective Clothing Equipment Contamination Amsacrine Decontamination Vanadium Compounds Phlebitis

No FAQ available that match "agents inhibit antineoplastic agents"